Australia is excellent at medical research, but dismal at translating that research into new medicines and treatments for patients. I'll explore why that is, what we're missing out on as a result, what is working well, and what we can do to realise the potential of medical research. The stories of three heroes of medical research can show us the way. Brigitte Smith has twenty years’ experience in venture capital, business strategy and start-up company operations. Brigitte has been investing and managing investments for GBS’s $450m of life science specialized venture capital funds since 1998. Brigitte is on the board of GBS portfolio companies AirXpanders Inc, Endoluminal Sciences Pty Ltd, Neuromonics Pty Ltd, Proacta Inc, and Vivive Inc. Brigitte was the founding investor and chair of Pharmaxis Pty Ltd. Prior to founding GBS Brigitte worked in the U.S. and Australia in operating roles with early stage technology based companies, and at Bain & Company as a strategic management consultant. Ms Smith has a B. Chem Eng (Honours) from the University of Melbourne, and as a Fulbright Scholar completed a MBA (Honours) from the Harvard Business School and a MALD from the Fletcher School of Law and Diplomacy, both in Boston, USA. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
Very Useful information Thank you!!
ReplyDelete#ProRelix #Clinical #Research is medical research where people volunteer to participate in carefully conducted investigations that ultimately uncover better ways to treat, prevent, diagnose, and understand human disease. Prorelix | Medical Research Courses
I liked Your article keep on sharing
ReplyDeleteClinical Research Courses